Videos
Scientific Session EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care Large B-cell lymphomas
Sirpa Leppä
Scientific Session EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care Mantle cell lymphoma
Igor Aurer
Scientific Session EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care Follicular lymphoma
Kim Linton
Scientific Session EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care HIV-related lymphomas
Marcus Hentrich
Scientific Session EHA-LYG/GHSG Joint Session: EHA Clinical Practice Guidelines in Lymphoid Malignancies - From Recommendations to Patient Care Peripheral T-cell lymphoma
Francesco d'Amore
Scientific Session Early Stages Abstract T082: Radiation-free initial treatment of early-stage favorable classic Hodgkin Lymphoma (RAFTING) trial: three-year follow-up
Jan Maciej Zaucha
Scientific Session Early Stages Abstract T083: Integrating E-HIPI and Interim PET to Refine Risk Stratification in Early-Stage Classic Hodgkin Lymphoma
Alessandro Cellini
Main Program Opening Ceremony with Keynote Lecture & Awards Welcome Address
Peter Borchmann
Main Program Opening Ceremony with Keynote Lecture & Awards A Generation of Research on Hodgkin Lymphoma
Volker Diehl
Main Program Opening Ceremony with Keynote Lecture & Awards Karl-Musshoff Awards & Poster Awards
Dennis Eichenauer, Peter Borchmann, Paul J. Bröckelmann, Justin Ferdinandus
Main Program Opening Ceremony with Keynote Lecture & Awards Keynote Lecture: Changing treatment paradigms in B cell Lymphoma
Gilles Salles
Scientific Session HL in Children and Adolescents Treatment Evolution in Pediatric Hodgkin Lymphoma: From Research to Real-World Impact
Maurizio Mascarin
Scientific Session HL in Children and Adolescents Precision Medicine in Pediatric HL / Harmonized Pediatric HL Protocol in South Africa
Jennifer Geel
Scientific Session HL in Children and Adolescents Abstract T071: The Genomic Landscape of Pediatric High-Risk Hodgkin Lymphoma: A Liquid Biopsy Study of COG AHOD1331
Lianna Marks
Scientific Session HL in Children and Adolescents Abstract T072: Body-Size Normalisation of Metabolic Tumour Volume in Paediatric Hodgkin Lymphoma: Does MTV/BSA Improve Prognostic Stratification and Reclassify Smaller Children?
Claire Gowdy
Scientific Session Translating ctDNA into clinical routine Circulating Tumor DNA Analysis for Classification and MRD Assessment – Experience of the German Hodgkin Study Group
Sven Borchmann
Scientific Session Translating ctDNA into clinical routine Workshop Report
Christian Steidl
Scientific Session Translating ctDNA into clinical routine Abstract T048: A Reproducible Mutation- versus Copy-Number-Enriched Genomic Axis Underlies Molecular Subtypes of Classic Hodgkin Lymphoma
Cara Paulina Lange
Scientific Session Biology & Pathology The Biology of HRS Cells
Ralf Küppers
Scientific Session Biology & Pathology Novel Insights Into the Microenvironment of Hodgkin Lymphoma
Tomohiro Aoki
Scientific Session Biology & Pathology Abstract T046: Functional characterization of STAT6 mutations as oncogenic drivers in classical Hodgkin lymphoma (cHL)
Luisa Tasselli
Scientific Session Biology & Pathology Abstract T047: Artificial intelligence predicts EBV status and reveals prognostic morphology phenotypes in advanced-stage classic Hodgkin lymphoma
Hishan Tharmaseelan
Scientific Session Living Beyond Lymphoma Evaluating Late Effects of Contemporary Treatments - Competing Risks & Novel Approaches
Caroline Dietrich
Scientific Session Living Beyond Lymphoma In Conversation with GHSG Patient Representatives: Building a Bridge Between Cancer Treatment and Everyday Life – Challenges After Lymphoma
Karolin Behringer, GHSG patient representatives
Scientific Session Living Beyond Lymphoma Abstract T092: Patients with a history of Hodgkin lymphoma have lower quality of life than matched comparators regardless of time elapsed since diagnosis
Peter Kamper
Scientific Session Living Beyond Lymphoma Abstract T093: The MyHodgkin MyHealth App: patient-derived data for tracking Hodgkin Lymphoma survivorship
Nicole Wong Doo
Scientific Session Advanced Stages Abstract T002: Simplified Geriatric Assessment (sGA) in Older Patients With Classical Hodgkin Lymphoma (cHL): The Prospective ELDHL Project of the Fondazione Italiana Linfomi (FIL)
Vittorio Ruggero Zilioli
Scientific Session Advanced Stages Abstract T003: Durable Remissions and Late Immune-Related Toxicities After Frontline Pembrolizumab + AVD in Classic Hodgkin Lymphoma
Ryan Lynch
Scientific Session Special Cases & Situations HL in Pregnancy
Anne-Sophie Robertz
Scientific Session Special Cases & Situations Critical Organ Failure at Presentation
Hishan Tharmaseelan
Scientific Session Special Cases & Situations Anti-PD1 Tx in Pre-Existing Autoimmune Disease
Yvonne Jauw
Scientific Session Special Cases & Situations Workshop Report “Grassroot Initiative in Classic Hodgkin Lymphoma”
Ranjana Advani, Peter Omondi Oyiro
Scientific Session NLPHL Clinical Implications of Growth Patterns
Dennis Eichenauer
Scientific Session NLPHL Treatment Strategies
Jamie Flerlage
Scientific Session NLPHL Abstract T101: Single-Nuclei and Spatial Transcriptomic Analysis of Nodular Lymphocyte- Predominant Hodgkin Lymphoma (NLPHL)
Hua Dong
Scientific Session NLPHL Abstract T102: Malignant LP cells build a stroma-poor, avascular niche that concentrates IDO1+ macrophages and excludes regulatory T cells in NLPHL and THRLBCL
Ilja Kalashnikov
Scientific Session Relapsed & Refractory HL 2L Treatment of HL in Era of Novel Agents
Alison Moskowitz
Scientific Session Relapsed & Refractory HL Revisiting the Role of Stem Cell Transplantation in rrHL
Bastian von Tresckow
Scientific Session Relapsed & Refractory HL Abstract T106: Phase 1 PRIMAVERA Study of the PRMT5 Inhibitor AZD3470 in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma
Pier Luigi Zinzani
Scientific Session Relapsed & Refractory HL Abstract T107: Treatment patterns and survival outcomes of patients relapsing after frontline Nivolumab-AVD in advanced stage classical Hodgkin lymphoma (cHL)
Harsh Shah
Scientific Session Relapsed & Refractory HL Abstract T108: Primary Analysis of the GHSG Pembro-CORE Trial: PET-Adapted PD-1-Based Salvage Therapy Omitting High-Dose Chemotherapy in First-Relapsed Hodgkin Lymphoma
Hishan Tharmaseelan
Main Program Best of ISHL14 Best of ISHL14
Ranjana Advani
Main Program Best of ISHL14 Farewell
Peter Borchmann
ISHL14 Videos
To watch the recorded talks please log in using the same credentials you have received by E-mail.
An E-mail with the password has been sent to all participants.
If you are registered for the conference but did not receive your credentials please contact info@hodgkinsymposium.org.
Your Feedback
We would be very grateful if you could take a moment to share your feedback using the form below. Your feedback is highly appreciated and will help us further improve future conferences.